February 19, 2015
Chuikyo General Meeting The Central Social Insurance Medical Council (Chuikyo) approved NHI price listing for 26 products/14 active pharmaceutical ingredients (APIs), including Takeda Pharmaceutical’s Takecab Tablets 10 mg and 20 mg (vonoprazan fumarate), a treatment for acid-related diseases, and Chugai...read more